Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Science , 339(6119), 548554
16% of patients were insulin naive
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure
After you eat, it helps signal fullness to the brain, slows how quickly food leaves the stomach, supports insulin release when blood sugar rises, and helps reduce glucagon, a hormone that raises blood sugar
M.OscarssonJ.StumvollM.JermutusL.et al (2021)
US$ 29.03
US$ 25.90
US$ 20.08
US$ 25.34
US$ 28.31
